Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib.
Skin Cancer Unit, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, DE-69120 Heidelberg, Germany. c.gebhardt@dkfz.de.
Christoffer
C
Gebhardt
Janina
J
Staub
Astrid
A
Schmieder
Sergij
S
Goerdt
Jochen
J
Utikal
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001706:Biopsy; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D017809:Fatal Outcome; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007642:Keratosis; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D008875:Middle Aged; D008883:Miliaria / Q000139:chemically induced* / Q000175:diagnosis; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects*; D013997:Time Factors; D016896:Treatment Outcome; D000077484:Vemurafenib
D000970:Antineoplastic Agents; D007211:Indoles; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf